← Human Trials & Peer-Reviewed Studies
Women's experiences after early versus postponed oxytocin treatment of slow progress in first childbirth--a randomized controlled trial
Plain-language guide to PMID 22578752 (2012): randomized controlled trial study of Oxytocin in 536 women.
Key Facts
- PMID
- 22578752
- Journal
- Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives
- Year
- 2012
- Study type
- Randomized Controlled Trial
- Authors
- Bergqvist L et al. (7 authors)
- DOI
- 10.1016/j.srhc.2012.03.003
- Registered trial
- NCT01263158
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Oxytocin, published as a randomized controlled trial.
The aim was to compare the childbirth experiences of primiparous women with slow labour progress who had received early versus postponed oxytocin augmentation.
Who Took Part
According to the abstract, 536 women were involved.
By PubMed's age tags, the people studied were adults, women only.
The population included healthy primiparous women with slow labour progress after a normal pregnancy and spontaneous onset of active labour at term who had taken part in a randomized controlled trial at two delivery units in Sweden comparing early versus postponed oxytocin augmentation.
A total of 536 women were sent the Childbirth Experience Questionnaire (CEQ) one month postpartum.
How the Study Was Run
The researchers set it up as a randomized study.
Because people in this Oxytocin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
The 22-item questionnaire assesses four domains of the childbirth experience.
Main outcomes were the four domains of the CEQ: Own capacity, Professional support, Perceived safety and Participation.
What Was Measured
PubMed files the paper under topics including Cesarean Section, Labor, Induced, Obstetric Labor Complications, Oxytocics, Oxytocin, Parturition and Patient Satisfaction.
What This Means in Plain Language
The paper is a randomized study of Oxytocin in 536 women.
With several hundred people or more, it is a fairly large study for this kind of research.
Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2012 (Sexual & reproductive healthcare : official journal of the Swedish Association of Midwives), a journal based in Netherlands.
More context: the Oxytocin compound page.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.